Clinical profile of athletes with hypertrophic cardiomyopathy

Circulation: Cardiovascular Imaging

Volumn 8, Issue 7, 2015, Pages

  Sheikh, Nabeel ^a,b   Papadakis, Michael ^a,b   Schnell, Frédéric ^c   Panoulas, Vasileios ^d   Malhotra, Aneil ^a,b   Wilson, Mathew ^e   Carré, François ^c   Sharma, Sanjay ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^c INSERM   (France)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

Author keywords

Echocardiography; Exercise physiology; Hypertrophic cardiomyopathy; Left ventricular hypertrophy; Primary prevention

Indexed keywords

ADOLESCENT; ADULT; AMBULATORY MONITORING; ARTICLE; ATHLETE; ATRIAL FIBRILLATION; BLOOD PRESSURE; BODY SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FAMILY HISTORY; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART LEFT VENTRICLE WALL; HEART MURMUR; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; OXYGEN CONSUMPTION; PHENOTYPE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; SENSITIVITY AND SPECIFICITY; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; T WAVE INVERSION; TISSUE DOPPLER IMAGING; CARDIOMYOPATHY, HYPERTROPHIC; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOCARDIOGRAPHY; EXERCISE INDUCED CARDIOMEGALY; FRANCE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART STROKE VOLUME; HYPERTROPHY, LEFT VENTRICULAR; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; ATHLETES; CARDIOMEGALY, EXERCISE-INDUCED; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FRANCE; HEART CONDUCTION SYSTEM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; LONDON; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; SEDENTARY LIFESTYLE; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84942893115     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.114.003454     Document Type: Article

References (31)

1. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-1092. doi: 10.1161/CIRCULATIONAHA.108.804617.
2. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation. 1995;91:1596-1601.
3. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart. 2005;91:1380-1382. doi: 10.1136/hrt.2005.060962.
4. Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A. Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2014;114:1383-1389. doi: 10.1016/j.amjcard.2014.07.070.
5. Basavarajaiah S, Boraita A, Whyte G, Wilson M, Carby L, Shah A, Sharma S. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51:2256-2262. doi: 10.1016/j.jacc.2007.12.061.
6. Maron BJ, Klues HG. Surviving competitive athletics with hypertrophic cardiomyopathy. Am J Cardiol. 1994;73:1098-1104.
7. Wilson MG, Chandra N, Papadakis M, O'Hanlon R, Prasad SK, Sharma S. Hypertrophic cardiomyopathy and ultra-endurance running - two incompatible entities? J Cardiovasc Magn Reson. 2011;13:77. doi: 10.1186/1532-429X-13-77.
8. Basavarajaiah S, Wilson M, Whyte G, Shah A, McKenna W, Sharma S. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol. 2008;51:1033-1039. doi: 10.1016/j.jacc.2007.10.055.
9. Sheikh N, Papadakis M, Ghani S, Zaidi A, Gati S, Adami PE, Carré F, Schnell F, Wilson M, Avila P, McKenna W, Sharma S. Comparison of electrocardiographic criteria for the detection of cardiac abnormalities in elite black and white athletes. Circulation. 2014;129:1637-1649. doi: 10.1161/CIRCULATIONAHA.113.006179.
10. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;58:e212-e260. doi: 10.1016/j.jacc.2011.06.011.
11. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295-301. doi: 10.1056/NEJM199101313240504.
12. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114:1633-1644. doi: 10.1161/CIRCULATIONAHA.106.613562.
13. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bjørnstad HH, Carrè F, Deligiannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes NA III, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ; Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31:243-259. doi: 10.1093/eurheartj/ehp473.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463. doi: 10.1016/j.echo.2005.10.005.
15. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167-184.
16. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107-133. doi: 10.1016/j.echo.2008.11.023.
17. Papadakis M, Carre F, Kervio G, Rawlins J, Panoulas VF, Chandra N, Basavarajaiah S, Carby L, Fonseca T, Sharma S. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J. 2011;32:2304-2313. doi: 10.1093/eurheartj/ehr140.
18. Sharma S, Elliott PM, Whyte G, Mahon N, Virdee MS, Mist B, McKenna WJ. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol. 2000;36:864-870.
19. Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 2003;108:395-398. doi: 10.1161/01. CIR.0000084500.72232.8D.
20. Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol. 2001;88:53-58.
21. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H, O'Mahony C, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Alfonso F, Basso C, Cardim NM, Gimeno JR, Heymans S, Holm PJ, Keren A, Lionis C, Muneretto C, Priori S, Salvador MJ, Wolpert C. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;1-55.
22. Sharma S, Elliott P, Mahon N, Whipp B, Whyte G, Jones S, Mckenna WJ. Utility of cardiopulmonary exercise in the assessment of clinical determinants hypertrophic cardiomyopathy. Am J Cardiol. 2000;86:162-168.
23. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med. 1987;316:780-789. doi: 10.1056/NEJM198703263161305.
24. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation. 2006;114:216-225. doi: 10.1161/CIRCULATIONAHA.105.583500.
25. Chikamori T, Counihan PJ, Doi YL, Takata J, Stewart JT, Frenneaux MP, McKenna WJ. Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19:507-512.
26. Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation. 1995;92:2886-2894.
27. Moreo A, Ambrosio G, De Chiara B, Pu M, Tran T, Mauri F, Raman SV. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging. 2009;2:437-443. doi: 10.1161/CIRCIMAGING.108.838367.
28. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475-484. doi: 10.1016/j.jcmg.2012.08.019.
29. Lewis JF, Spirito P, Pelliccia A, Maron BJ. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing "athlete's heart" from hypertrophic cardiomyopathy. Br Heart J. 1992;68:296-300.
30. Schnell F, Riding N, O'Hanlon R, Axel Lentz P, Donal E, Kervio G, Matelot D, Leurent G, Doutreleau S, Chevalier L, Guerard S, Wilson MG, Carré F. Recognition and significance of pathological T-wave inversions in athletes. Circulation. 2015;131:165-173. doi: 10.1161/CIRCULATIONAHA.114.011038.
31. Basavarajaiah S, Wilson M, Junagde S, Jackson G, Whyte G, Sharma S, Roberts WO. Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma. Br J Sports Med. 2006;40:727-9; discussion 729. doi: 10.1136/bjsm.2005.024596.